Corpus ID: 44403463

Role of LDH ( Lactate dehydrogenase ) in preeclampsia – marker : An observational study

@inproceedings{Umasatyasri2015RoleOL,
  title={Role of LDH ( Lactate dehydrogenase ) in preeclampsia – marker : An observational study},
  author={Y. Umasatyasri and I. Vani and P. Shamita},
  year={2015}
}
Serum LDH is abnormal in a host of disorders, there fore the total serum LDH is highly nonspecific test. In preeclampsia also LDH may be e levated and can indicate the prognosis for both mother and fetus. The present study wa serum LDH as a marker of preeclampsia associated with increased incidence of maternal com plications like abruption placenta HELLP syndrome, cerebrovascular accidents etc. in the present study . There was an increase in maternal morbidity with increasing serum LDH levels… Expand
Role of Serum Lactate Dehydrogenase in Preeclampsia in Assessing The Maternal And Fetal Outcome
Objective: Preeclampsia is responsible for significant maternal and perinatal mortality worldwide. Lactate dehydrogenase is mainly an intracellular enzyme. The levels of LDH in serum are increased inExpand
A REVIEW ON ESTIMATION OF SERUM LDH AND URIC ACID IN HYPERTENSIVE VS NORMAL PREGNANT WOMAN AND ITS CORRELATION WITH MATERNAL OUTCOME in A TERITIARY CARE HOSPITAL.
TLDR
High serum LDH and uric acid levels have significant association with severity of disease and maternal outcomes in patient of preeclampsia and can be considered as a prognostic tool from early trimester. Expand
Role of serum LDH in preeclampsia as a prognostic factor – a cross sectional case control study in tertiary care hospital
TLDR
Lactate dehydrogenase is a useful biochemical marker that reflects the severity of pre-eclampsia and as a prognosticator of the disease severity, and detection of high-risk patients with increased levels of LDH mandate close monitoring and management to prevent maternal and fetal morbidity and mortality. Expand
Lactate Dehydrogenase as a Biochemical Marker of Adverse Pregnancy and Fetal Outcome in Preeclampsia: A Comparative Study
Aims: Current study has been done to analyse the serum levels of lactate dehydrogenase (LDH) as a prognostic marker for pre-eclampsia and to substantiate the severity of preeclampsia and adverseExpand
Correlation of serum lactate dehydrogenase and pregnancy induced hypertension with its adverse outcomes
TLDR
Serum LDH showed significant association with severity of disease and maternal and fetal complications in patients with preclampsia-eclamapsia and its severity was assessed. Expand
Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia, Gujarat
TLDR
Higher serum LDH levels during pregnancy have significant association with severity of disease and maternal and fetal outcomes in patients of preeclampsia and eclampsIA and can be considered as a supportive prognostic tool from early third trimester. Expand
Lactate dehydrogenase and maternal and perinatal outcome in preeclamptic women
TLDR
LDH levels are associated with severity of preeclampsia and occurrence of maternal and fetal complications. Expand
Serum LDH in Preeclampsia & Eclampsia and Maternal Outcomes
TLDR
It is concluded that High serum LDH levels correlate well with poor maternal and perinatal outcomes in patients of Preeclampsia and E Clampsia. Expand

References

SHOWING 1-7 OF 7 REFERENCES
Lactic Dehydrogenase: A Biochemical Marker for Preeclampsia–Eclampsia
TLDR
High serum LDH levels correlate well with the severity of the disease, maternal and perinatal outcome and poor outcomes in patients of preeclampsia and eClampsia. Expand
Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small-for-gestational-age infants.
TLDR
It is suggested that an increase in LDH is predictive of SGA infants in preeclamptic pregnancy, especially in those with normal liver function, particularly in those in the appropriate-for-gestational-age group. Expand
Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death.
TLDR
A subgroup of patients with fulminant hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome, manifesting extreme elevation of aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) levels and abnormal mental status are reported, at high risk for mortality. Expand
Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity.
TLDR
The presence of nausea and vomiting, epigastric pain, or both in association with admission laboratory values that are in excess of the cutoffs for lactate dehydrogenase, aspartate aminotransferase, and uric acid concentrations is predictive of high risk of morbidity for the patient with severe preeclampsia. Expand
Expectant management of early onset, severe pre‐eclampsia: perinatal outcome
TLDR
The perinatal outcome of expectant management of early onset, severe pre‐eclampsia is evaluated. Expand
LDH as biochemical marker of adverse pregnancy outcome in severe preeclampsia
  • Med Sci Monit.,
  • 2005
Factors that influence morbidity, and mortality in severe preeclampsia, eclampsia and HELLP syndrome
  • Saudi Med J.,
  • 2006